论文部分内容阅读
目的:探讨脓毒血症患者血降钙素原、D-二聚体水平对患者预后判断的价值。方法:取2015年12月到2016年12月间本院收治的60例脓毒血症患者进行研究,根据患者入院28d预后状况将患者分为死亡组(n=26)和存活组(n=34),对所有患者的资料实施回顾性分析,统计对比两组患者的血降钙素原、D-二聚体水平状况。结果:死亡组患者血降钙素原、D-二聚体水平与存活组相比明显较高,血降钙素原、D-二聚体均为阳性患者死亡率与均为阴性、一项阳性患者相比明显较高,P<0.05。结论:脓毒血症患者血降钙素原、D-二聚体水平可辅助判定患者预后状况。
Objective: To investigate the prognostic value of serum procalcitonin and D-dimer levels in patients with sepsis. Methods: Sixty patients with sepsis admitted to our hospital from December 2015 to December 2016 were enrolled. Patients were divided into death group (n = 26) and survival group (n = 34). The data of all the patients were retrospectively analyzed. The levels of blood procalcitonin and D-dimer were compared between the two groups. Results: The levels of blood procalcitonin and D-dimer in the death group were significantly higher than those in the survival group. The mortality and the incidence of both the patients with positive blood plasma procalcitonin and D-dimer were both negative. Positive patients were significantly higher, P <0.05. Conclusion: The serum levels of procalcitonin and D-dimer in patients with sepsis can help determine the prognosis of patients.